Assessment of primary care facilities for cardiovascular disease preparedness in Madhya Pradesh, India by unknown
RESEARCH ARTICLE Open Access
Assessment of primary care facilities for
cardiovascular disease preparedness in
Madhya Pradesh, India
Abhijit Pakhare1, Sanjeev Kumar1, Swati Goyal2 and Rajnish Joshi3*
Abstract
Background: Government of India has launched National Program for Prevention & Control of Cancer, Diabetes,
Cardiovascular Diseases and Stroke (NPCDCS) to address high prevalence of non-communicable diseases (NCDs) in
India. Cardiovascular diseases (CVDs) constitute a significant portion of NCD burden. While this program is yet to be
launched in all districts of Madhya Pradesh state of India, we performed this study to understand facility-level gaps
that need to be addressed to improve CVD services in primary care provided by the public sector.
Methods: This is a cross-sectional questionnaire based study. A standardized questionnaire was self-administered to 85
medical officers from as many primary care facilities from 24 districts of the state. These medical officers were working
in two types of primary care facilities – primary health center (PHC) and community health centers (CHC). Facilities
were assessed for 36 items in 5 domains (human-resource, equipment, drug supplies, point-of-care tests and laboratory
services) with a focus on management of hypertension and diabetes mellitus in primary-care. Each item was to be
answered as either present or absent at the facility where medical officer was working. We compared availability of an
item across two levels of primary care facilities. All statistical analysis were done using Microsoft Excel.
Results: Availability of facilities was least in laboratory services, and human resource domains followed by drugs, and
better in equipment and point-of-care supply domains. Across these domains, availability of items in CHCs was (37.1,
49.0, 56.1, 67.9 and 80.9 % respectively) and in PHCs (11.8, 18.2, 44.2, 55.1, and 55.3 % respectively).
Discussion: Current facility assessment study shows critical gaps in key items required for management of NCDs at
primary care level. Human resource and laboratory services need to be strengthened the most, followed by sustained
availability of all required drug classes, equipment and related supplies, and upgrading point-of-care testing. There are
larger gaps in PHCs, which are level 1 facilities, as compared to CHCs, which are level 2 facilities in primary-care.
Conclusions: Increasing burden of NCDs like hypertension and diabetes mellitus necessitates public health response
through health systems. Therefore health system preparedness in form of trained human resources, functional
laboratories and well stocked pharmacies are essential in primary care facilities.
Background
Non-communicable diseases (NCDs), especially cardiovas-
cular diseases (CVD; coronary artery, cerebro-vascular, and
peripheral vascular diseases) are a leading cause of mortal-
ity among middle aged and older adults in India [1]. Preva-
lence of CVD risk factors (smoking, hypertension, diabetes
mellitus, obesity, dyslipidemia, unhealthy diet, and reduced
physical activity) is increasing, and recent studies report up
to 40 % of Indian adults to be hypertensive [2], and 10 % to
be diabetic [3]. Risk factor control requires a multidisciplin-
ary approach, which includes approaching social determi-
nants of health, health-care financing, improving medical
education, and health system strengthening to better man-
age risk factors [4]. Except for smoking and low vegetable
and fruit diet, most of the risk factors for CVD are more
prevalent in high socioeconomic groups [5]. However con-
sidering large proportion of population in lower so-
cioeconomic group, it has been suggested that most
of the burden of risk factors is contributed by poor
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and underprivileged [6], which puts higher onus on
public health delivery system for NCD care in India.
Government of India has responded to the increasing
burden of NCDs through launch of a National Program for
Prevention & Control of Diabetes, Cardiovascular Diseases
and Stroke (NPCDCS) in 2008 [7]. Currently in its second
phase, the program includes 100 of 640 districts (15.6 %) in
India. The NPCDCS aims at integration of NCD interven-
tions in the overall public-health delivery framework for
optimization of scarce resources and provision of seamless
services to patients as also for ensuring long term sustain-
ability of interventions [7]. WHO developed a global moni-
toring framework to enable global tracking of progress in
preventing and controlling major non-communicable dis-
eases - cardiovascular disease, cancer, chronic lung diseases
& diabetes and their key risk factors. Targets and indicators
for availability of essential non-communicable disease
medicines and basic technologies to treat major non-
communicable diseases have been described under
national systems response category. An 80 % availability of
the affordable basic technologies and essential medicines,
including generics, required to treat major non-
communicable diseases in both public and private facilities
is expected to be achieved by 2025. In this context Govern-
ment of Madhya Pradesh has launched free drug distribu-
tion and laboratory investigation scheme in public health
facilities. While this is a work in progress, and the program
is likely to be scaled up to all the districts of the country, it
is important to understand existing infrastructure and
readiness of public health infrastructure for NCD care.
Public health delivery system in rural India consists of
Primary Health Centers (PHC; n ~ 25,000; catchment
population ~30,000) as a level 1 facility, and a Community
Health Center (CHC; n ~ 5000; catchment population ~
100,000) a level 2 facility. CHC functions as a level 1 facil-
ity for the village it is located-in, and level 2 facility for the
villages catered by adjoining PHCs in the catchment area.
Together, these facilities are designed to meet most pri-
mary care needs through medical doctors, paramedical
staff, basic investigations and essential drugs [8]. Over the
years, focus of primary care in India has been communic-
able diseases, and reproductive and child health services.
As a consequence, it is likely that some key facility-based
elements required for NCD-care may be lacking. The
current study was performed to understand availability of
health-facility level infrastructure for delivery of CVD care
in PHCs and CHCs in state of Madhya Pradesh.
Methods
Setting
Madhya Pradesh is second largest state in India by area,
and sixth by population (population ~ 72 million (2011
census)) and has network of 1157 PHCs and 334 CHCs
[9]. Between May and August 2013, Department of Public
Health and Family Welfare, Government of Madhya Pra-
desh, and All India Institute of Medical Sciences Bhopal
conducted workshops for medical officers posted in PHCs
and CHCs of the state. Purpose of these workshops was to
upgrade skills with regards to identification and manage-
ment of hypertension, diabetes and CVD risk factors. Re-
quest for nomination for these workshops were sent by
Directorate Health Services to Chief Medical Officers of
24 districts. These districts have a network of 169 CHCs
and 640 PHCs. Nominations of 66 and 56 medical officers
of PHCs and CHCs were received of which 48 and 39
attended the workshops respectively. These Medical offi-
cers belonged to five districts where NPCDCS has been
launched in the state (Chindwara, Dhar, Hoshangabad,
Jhabua and Ratlam) and another nineteen districts (Bala-
ghat, Betul, Bhind, Bhopal, Dindori, Gwalior, Khandwa,
Khargone, Mandsaur, Morena, Raisen, Satna, Sehore,
Seoni, Shahdol, Shajapur, Shivpuri, Sidhi, and Ujjain).
We performed a questionnaire-based survey to under-
stand facility level infrastructure in the State.
Participants
A total of 85 (97.7 %) Medical officers (38 from CHC
and 47 from PHCs) participated in the survey and
provided facility level information. Workshop was con-
ducted in batches, with a maximum batch size of 20. A
total of five workshops were conducted, and questionnaire
was administered at the start of each workshop, and par-
ticipation was voluntary. In order to ensure a correct
reporting, and to protect participants from potential
administrative repercussions on reporting of deficien-
cies in the system, we decided not to collect any per-
sonal identifiers (Name of respondent, or the facility)
for this study. Hence we requested Institutional Human
Ethics Committee (IHEC) of AIIMS Bhopal for a waiver
of consent. This request and the study design were
approved by the IHEC of AIIMS Bhopal.
Procedure
We designed a facility assessment questionnaire based
on Indian Public Health Standards (IPHS) for PHC
and CHC [10], and World Health Organization pack-
age of essential NCD interventions (WHO PEN)
guidelines [11]. We initially consulted core team of
medical and public health specialists (who were also
involved in the designing training curriculum for the
medical officers), to draw up a list of tools and tech-
nologies required for primary care management of
key NCDs. Items in this list that were also included
in either WHO-PEN or IPHS were retained. World
Health Organization has proposed a package of essen-
tial NCD interventions (WHO PEN) for low resource
settings [11]. This package lists simple technologies
that must be available, and others to be added when
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resources permit. While WHO-PEN provides for a list of
essential technologies and drugs required in primary care,
it neither details human resource requirements, nor does
it discriminate between levels of Primary care. IPHS has
separate standards for PHC & CHC, including human
resources, infrastructure, equipment & drugs, but does
not have a NCD focus. We took most items from the PEN
and relevant items from IPHS standards in the current
study. The complete set of expanded questionnaire with
source of individual items is presented in Table 1. We
divided all the items of the questionnaire in five domains
(Human resources, equipment, point-of-care supplies,
laboratory based tests and drugs), and for two disease
conditions (hypertension and diabetes). We included four
basic drugs needed in management of hypertension
(Angiotensinin Converting Enzyme Inhibitors (ACEI)/
Angiotensin receptor blockers (ARB), Beta blockers,
Calcium channel blockers, (CCB) and Thiazide diuretics)
and four drugs commonly used in management of
diabetes mellitus (Metformin, Glibenclamide, Glimiperide,
and Insulin) in the questionnaire. In each domain, we
provided a list of facilities, and expected answer was to be
either Yes or No or do-not know (coded as 1, 0 and 99
respectively). We grouped key facilities as needed in man-
agement of diabetes and hypertension to understand
preparedness for their management in public health
system. There were two versions of the questionnaire; first
version with 15 items was administered to 48 medical
officers. We expanded the questionnaire in later part
of the study, largely to assess for availability of essen-
tial drugs and medications pertaining to NCDs. The
final version was expanded to include 36 items, which
was administered to 37 medical officers who reported
in remaining batches.
Statistical analysis
We performed descriptive analysis for the collected data
and analyzed frequencies separately for community
health centers (a facility with higher level of functional-
ity) and primary health centers (a facility with a lower
level of functionality). We averaged proportions for indi-
vidual items under a domain, to indicate coverage in a
particular domain. For instance, to indicate overall drug
availability, we averaged proportions of all drug classes
included in the survey. To estimate readiness for individ-
ual diseases such as hypertension or diabetes mellitus,
we used disease-specific indicators in point-of-care tests,
laboratory tests, and drug domains. Statistical analysis
was performed in Microsoft Excel version 2010.
Results
Overall availability of facilities was lowest in the domains
of laboratory services and human resource. Availability
of all drug classes required for management of diabetes,
hypertension and their acute complications was inter-
mediate. Equipment and point of care supplies had
better availability (Fig. 1). Availability of various facilities
amongst CHCs of districts where NPCDCS is being
piloted (n = 14) and other districts (n = 25) was similar.
In Human resource domain, while two medical officers
were available in most CHCs, this was the case in less
than half PHCs sampled. Similarly availability of Labora-
tory technicians and Health Educators was also signifi-
cantly lower. Nutritionists and physiotherapists were
mostly not available at either level of care (Table 2). In
equipment domain, sphygmomanometer was available at
all PHCs and CHCs, measuring tape was available in
about 80 % of facilities, and height measurement equip-
ment was available in about half of all facilities.
Glucometer was available in most CHCs, but in less than
half of the PHCs. ECG machine was available in only
about one-third of CHCs, and less than 10 % of PHCs
(Table 2). While point of care test supplies (blood glucose
estimation strips/glucostrips, needles, urinary protein
strips etc.) were available in most CHCs, their availability
was significantly lower in PHCs. Availability of urinary
ketone strip, useful for diagnosis of diabetes related
complication, was available in only half of all CHCs, and a
third of all PHCs. Availability of laboratory based tests was
negligible at PHCs, and low at CHCs (Table 2).
Among facilities for primary care management of
hypertension, equipment for diagnosis and at least one
anti-hypertensive drug was available at most PHCs and
CHCs. In contrast, facility to screen for diabetes mellitus
with help of glucometer was reported to be not available
at more than half of PHCs and about a fifth of all CHCs.
Availability of supplies or services to screen for compli-
cations related to these conditions was much lower
(Table 2). Availability of drugs used in long-term treat-
ment of hypertension, diabetes mellitus, and their acute
complications was enquired from a subset of medical
officers. Two of the four basic drugs needed in manage-
ment of hypertension (beta-blockers and calcium chan-
nel blockers) were available at most PHCs and CHCs.
One of four drugs for management of diabetes mellitus
(metformin) was available at most CHCs and about two-
thirds of all PHCs. Other drugs used in management of
diabetes mellitus (other oral drugs and insulin) were
largely unavailable (Table 2).
Low dose aspirin, which is most useful and inexpen-
sive of all cardiovascular drugs was available at about
half of all facilities. Lipid lowering drugs were available
in less than one-sixth of all facilities. Nitrates were avail-
able at about three-fourths of all CHCs, and less than
half of all PHCs. On the contrary, dexamethasone, a
drug which is frequently misused in emergency manage-
ment of cardiovascular complications was available at
most PHCs and CHCs.
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Table 1 Domains, sub-groups and key items evaluated in the questionnaire
Domain Sub-group Key items evaluated Source of item
Human resource Two Medical Officers IPHS-PHC & CHC
Laboratory technician IPHS-PHC & CHC
Health Educator IPHS-PHC & CHC
Nutritionist IPHS-CHC (Dietician)
Physiotherapist IPHS-CHC
(Rehabilitation worker)
Equipment Equipment for diagnosis
of hypertension
Sphygmomanometer
(Mercury or Aneroid)a
IPHS-PHC & CHC,PEN
Equipment for diagnosis
of diabetes
Glucometerb PEN
Equipment for evaluation
of neuropathy
Percussion Hammer or Tuning fork IPHS-PHC & CHC,PEN
(Only tuning fork)
Equipment for assessment
of abdominal obesity
Measuring tape PEN
Equipment to measure
body mass index (BMI)
Stadiometer and weight machine IPHS-PHC & CHC, PEN
(Only weight machine)
Equipment to evaluate
cardiac complication
ECG machinea IPHS-CHC, PEN
Point-of-care testing supplies Glucose testing strips PEN
Lancets/needle for finger-prick PEN
Urinary strip for Ketonesb PEN
Urinary strip for Proteinsba PEN
Laboratory service Plasma Glucose estimationb PEN
Serum creatinineba IPHS-CHC, PEN
Serum lipid profile IPHS-CHC, PEN
HbA1C estimation None
Drugs Drug useful for long term
management of Hypertension
and Lipid lowering drugsa
ACEI/ARB (Enalapril,
Ramipril, Losartan etc.)
IPHS-PHC & CHC, PEN
Beta blocker (Atenolol) IPHS-PHC & CHC, PEN
CCB (Amlodepine) IPHS-PHC & CHC, PEN
Diuretic (Thiazide) IPHS-PHC & CHC, PEN
Lipid lowering (Atorvastatin) IPHS-PHC & CHC, PEN
Drug useful for long term
management of Diabetes MellitusLb
Metformin IPHS-PHC & CHC, PEN
Glibenclamide IPHS-PHC & CHC, PEN
Glimepiride IPHS-PHC & CHC, PEN
Pioglitazone IPHS-PHC & CHC, PEN
Insulin (any) IPHS-PHC & CHC, PEN
Drugs used in management
of chronic disease emergencies
and Dexamethasone, which
is frequently misused
Aspirin low dose IPHS-PHC & CHC, PEN
Nitrate (Sorbitrate) IPHS-PHC & CHC, PEN
Nifedepine IPHS-PHC & CHC, PEN
Frusemide IPHS-PHC & CHC, PEN
Dexamethasone IPHS-PHC & CHC
aThese facilities are key for primary care management of hypertension
bThese facilities are key for primary care management of diabetes mellitus
IPHS Indian Public Health Standards (for PHC (Primary health centers 2012) or CHC (Community health centers 2012)), PEN Package of essential non-communicable
disease interventions for primary care
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Discussion
Current facility assessment study shows critical gaps in
key items required for management of NCDs at primary
care level. Human resource and laboratory services need
to be strengthened the most, followed by sustained avail-
ability of all required drug classes, equipment and
related supplies, and upgrading point-of-care testing.
There are larger gaps in PHCs, which are level 1 facil-
ities, as compared to CHCs, which are level 2 facilities
in primary-care.
In order to achieve Universal health-care, there is a
need to strengthen primary-care delivery in India. Defi-
ciencies in human resources and laboratory services
assessed as part of this study impact a wide range of
health services beyond CVDs. While we have strength-
ened a wide range of specific services in primary-care in
India (such as immunization coverage [12], availability
of contraceptives [13], treatment of tuberculosis [14],
institutionalized child-births [15]). As it is expected that
70 % of the health budget needs to be earmarked for pri-
mary health care under universal health coverage [16],
we need to understand chain of CVD care resources
(human resource, drugs, and health technology (equip-
ment and laboratory services) that needs to be optimized
to specifically improve CVD coverage in India.
First component in this chain are human resources.
Management of CVDs like hypertension and diabetes
requires life-long behavioral change which needs to be
implemented using trained human resources. A PHC
provides coverage to at least 30,000 population of which
approximately 18,000 would be having age more than
15 years, which could mean about 3600 adults with
hypertension, and about 600 with diabetes mellitus con-
sidering prevalence of hypertension and diabetes to be
20 and 3.3 % respectively. Even if a third of them were
to seek care in the PHCs, medical doctors alone will
never be sufficient to meet all the CVD-care needs. A
medical doctor is considered necessary for first diagnosis
and subsequent follow-ups, various task-components
need to be shifted to supervised non-physician health
workers. For instance, screening for hypertension and
diabetes mellitus using blood pressure equipment or
glucometers can be done with help of trained health-
workers [17]. All individuals with hypertension and
diabetes need intensive health education, meaningful
dietary advice, and physical activity advice, reinforced
at every follow up visit. This can be achieved by train-
ing existing multi-purpose community health workers,
as it will not be feasible to employ dedicated nutrition-
ists and physiotherapists.
Second component in CVD-care chain are drugs. Drug
therapy in CVD is complex due to multiple drug
categories, and multiple drugs in each category. More
recent disease manegement guidelines have simplified
drug therapy protocols. Core list of medicines in WHO
PEN, required for implementing essential NCD interven-
tions includes four anti-hypertensives (ACEI, beta-blockers,
CCBs, and thaizide diuretic), three anti-diabetics (metfor-
min, glibenclamide, insulin), aspirin, nitrates, frusemide
and a lipid-lowering drug. Current study shows discordance
Fig. 1 Radar diagram depicting average availability of facilities for all indicators in five domains (Human resource, Equipment, Laboratory service,
Point-of-care supplies and Drugs). CHC- Community Health Centre; PHC- Primary Health Centre
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in availability of recommended class drugs. For example,
for hypertension beta blockers and CCBs are widely avail-
able but ACEI or Thiazide diuretcics are not. Further, we
found that availability of Aspirin and Lipid lowering drugs
was low, despite both of these drugs being useful in
prevention of vascular events in individuals who have dia-
betes mellitus (primary prevention) or in those who already
have had a previous event (secondary prevention). This
indicates lack of standard protocols, poor convergence and
patchy coordination between service providers and health
Table 2 Availability of key items in community health centers and primary health centers
Community health center Primary health center
Group Variable Available Total Percent Available Total Percent
Variables assessed in full version of questionnaire (n = 85)
Human resource Laboratory technician 35 38 92.11 12 47 25.53
Health Educator 17 38 44.74 10 47 21.28
Equipment Glucometer 32 38 84.21 20 47 42.55
Sphygmomanometer 38 38 100.00 47 47 100.00
ECG machine 13 38 34.21 5 47 10.64
Measuring tape 30 38 78.95 38 47 80.85
Stadiometer and Weight machine 23 38 60.53 23 47 48.94
Point-of-care testing supplies Glucostrips 33 38 86.84 24 47 51.06
Lancets/needle 35 38 92.11 34 47 72.34
Urinary ketone strip 22 38 57.89 17 47 36.17
Urinary protein strip 31 38 81.58 27 47 57.45
Laboratory test Plasma Glucose estimation 29 38 76.32 13 47 27.66
Serum creatinine 17 38 44.74 4 47 8.51
Serum lipid profile 10 38 26.32 4 47 8.51
HbA1C 2 38 5.26 2 47 4.26
Additional variables assessed in second version of questionnaire (n = 37)
Human resource Two Medical Officers 10 12 83.33 11 25 44.00
Nutritionist 2 12 16.67 0 25 0.00
Physiotherapist 1 12 8.33 0 25 0.00
Equipment Percussion hammer/tuning fork 6 12 50.00 12 25 48.00
Drugs Any anti-hypertensive 12 12 100.00 22 24 91.67
ACEI/ARB 6 12 50.00 7 25 28.00
Beta blocker 12 12 100.00 17 25 68.00
Calcium channel blocker (CCB) 11 12 91.67 21 25 84.00
Diuretic Thiazide 4 12 33.33 4 25 16.00
Atorvastatin 2 12 16.67 4 25 16.00
Any anti-diabetic drug 11 12 91.67 17 25 68.00
Metformin 10 12 83.33 17 25 68.00
Glibenclamide 2 12 16.67 4 25 16.00
Glimepiride 2 12 16.67 5 25 20.00
Pioglitazone 1 12 8.33 2 25 8.00
Insulin 5 12 41.67 3 25 12.00
Aspirin low dose 6 12 50.00 11 25 44.00
Frusemide 10 12 83.33 19 25 76.00
Sorbitrate 9 12 75.00 12 25 48.00
Nifedepine 10 12 83.33 17 25 68.00
Dexamethasone 11 12 91.67 23 25 92.00
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system managers. This could be rectified by consultative
group meeting of experts on subject including service
providers. It also calls for revision in the essential
drug lists of the State to keep pace with the changing
guidelines in management of CVDs.
Third component in CVD-care chain is technology,
which includes simple essential tools, and more com-
plex laboratory support. List of simple essential tools
in WHO PEN include a blood pressure measurement
device, measuring tape, weighing machine, glucometer,
urinary protein and ketone testing strips. Except for
blood pressure measurement device, these simple
technologies were deficient in many primary-care
facilities of Madhya Pradesh. Additional complex tech-
nologies to be added when resources permit include
facility to measure serum creatinine, lipids, and
electrocardiography that were mostly not available.
Average availability of these necessary drugs and tech-
nologies reported in the enrolled health-centers
ranged between 11 and 55 % in PHCs, and 37 and
80 % in CHCs.
A similar study was done by Mendis et al. [18] in
90 facilities across eight low-and-middle-income
countries, which reported similar deficiencies in hu-
man resources, drugs and technologies. Major defi-
cits were identified in health financing, access to
basic technologies and medicines, medical informa-
tion systems, and the health workforce [18]. The
growing burden of CVDs needs to be countered by
strengthening primary care facilities, especially for
hypertension and diabetes [19].
In current study, we were able to perform facility
assessment with minimal resources, and in a short
period of time. Since it was conducted by means of
questionnaire administration, directed towards work-
shop participants, it has some inherent limitations. First
limitation is selection bias as primary health centers
were conveniently sampled based on medical officers
posted in these PHCs who attended the workshop. This
bias is likely to oversample those PHCs which have
better facilities, as centers which did not have a medical
officer to spare at the time will not be sampled. PHCs
with such human resource deficit are more likely to lack
in facilities. Despite this limitation our study samples
facilities from half of all districts, and covers entire
geographic spread of Madhya Pradesh. Second limitation
is information bias, as we did not perform onsite assess-
ment, and responses were not verifiable and therefore
functionality of equipment could not be commented.
However, we believe that medical officers, are more
likely to over-report availability of certain key items. This
is especially true about perishable items such as drugs.
Last is measurement bias, as questionnaire based surveys
such as ours report facilities which are generally present,
rather than those present on a particular day or time. This
bias is also likely to be away from null, and over-report
availability of facilities. Despite these limitations, which
are all operationally away from null, we report critical gaps
in infrastructure which need to be addressed to make
NCD control successful in public health facilities focused
towards primary care.
Conclusions
Preparedness for comprehensive care from prevention,
early diagnosis to treatment and complication manage-
ment of NCDs at primary care level is sub-optimal due
to critical gaps in health facilities of Madhya Pradesh.
These gaps highlight need for strengthening of primary
health care systems for scaling up of interventions for
prevention and management of chronic diseases so as to
achieve goal of universal coverage and reduce the
burden of NCDs.
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